Works by Kumada, Takashi
Results: 269
Role of guanylate-binding protein 1 in the proliferation of invasive lung adenocarcinoma cells.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1434249
- By:
- Publication type:
- Article
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1464
- By:
- Publication type:
- Article
Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
- Published in:
- Pathology International, 2010, v. 60, n. 5, p. 351, doi. 10.1111/j.1440-1827.2010.02526.x
- By:
- Publication type:
- Article
Heat shock protein 20 (HSPB6) regulates apoptosis in human hepatocellular carcinoma cells: Direct association with Bax.
- Published in:
- Oncology Reports, 2014, v. 32, n. 3, p. 1291, doi. 10.3892/or.2014.3278
- By:
- Publication type:
- Article
Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of previous infection with hepatitis B virus on the incidence of hepatocellular carcinoma after sustained virologic response in patients with chronic hepatitis C virus infection.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 3, p. 137, doi. 10.1111/jvh.13907
- By:
- Publication type:
- Article
Factors linked to hepatocellular carcinoma development beyond 10 years after viral eradication in patients with hepatitis C virus.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 10, p. 919, doi. 10.1111/jvh.13728
- By:
- Publication type:
- Article
Long‐term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 9, p. 1293, doi. 10.1111/jvh.13562
- By:
- Publication type:
- Article
Reply to: 'Long‐term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus‐related decompensated cirrhosis'.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 7, p. 1099, doi. 10.1111/jvh.13514
- By:
- Publication type:
- Article
Long‐term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus–related decompensated cirrhosis.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 3, p. 508, doi. 10.1111/jvh.13457
- By:
- Publication type:
- Article
Comparison of liver disease state progression in patients with eradication of versus persistent infection with hepatitis C virus: Markov chain analysis.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 3, p. 538, doi. 10.1111/jvh.13444
- By:
- Publication type:
- Article
Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 12, p. 1446, doi. 10.1111/jvh.12967
- By:
- Publication type:
- Article
Characteristics and Outcomes of HCV Genotype-1-Infected Patients Treated with Peginterferon and Ribavirin Combination Therapy with Discordant HCV Responses 4 and 12 Weeks after Starting Therapy.
- Published in:
- Intervirology, 2014, v. 57, n. 5, p. 289, doi. 10.1159/000362721
- By:
- Publication type:
- Article
Prevalence of Hepatitis E Virus IgG Antibody in Japanese Patients with Hemophilia.
- Published in:
- Intervirology, 2008, v. 51, n. 1, p. 21, doi. 10.1159/000118792
- By:
- Publication type:
- Article
Prevalence of Low-Level Hepatitis B Viremia in Patients with HBV Surface Antigen-Negative Hepatocellular Carcinoma with and without Hepatitis C Virus Infection in Japan: Analysis by COBAS TaqMan Real-Time PCR.
- Published in:
- Intervirology, 2007, v. 50, n. 4, p. 241, doi. 10.1159/000101911
- By:
- Publication type:
- Article
Treatment of Chronic Hepatitis C with Interferon Alone or Combined with Ribavirin in Japan.
- Published in:
- Intervirology, 2006, v. 49, n. 1/2, p. 112, doi. 10.1159/000087273
- By:
- Publication type:
- Article
Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical Profiles of Asians with NAFLD: A Systematic Review and Meta-Analysis.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 6, p. 734, doi. 10.1159/000521662
- By:
- Publication type:
- Article
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 602, doi. 10.1159/000480256
- By:
- Publication type:
- Article
Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 521, doi. 10.1159/000480142
- By:
- Publication type:
- Article
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 11, p. N.PAG, doi. 10.1093/ofid/ofy268
- By:
- Publication type:
- Article
Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 7772, doi. 10.1002/cam4.5535
- By:
- Publication type:
- Article
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6980, doi. 10.1002/cam4.5495
- By:
- Publication type:
- Article
Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 325, doi. 10.1002/cam4.4854
- By:
- Publication type:
- Article
Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 20, p. 3796, doi. 10.1002/cam4.4763
- By:
- Publication type:
- Article
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241
- By:
- Publication type:
- Article
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909
- By:
- Publication type:
- Article
Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 3, p. 643, doi. 10.1002/cam4.218
- By:
- Publication type:
- Article
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 8, p. 579, doi. 10.3390/diagnostics10080579
- By:
- Publication type:
- Article
New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease.
- Published in:
- Biomarkers, 2018, v. 23, n. 4, p. 328, doi. 10.1080/1354750X.2018.1425915
- By:
- Publication type:
- Article
Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases.
- Published in:
- Biomarkers, 2013, v. 18, n. 1, p. 82, doi. 10.3109/1354750X.2012.738249
- By:
- Publication type:
- Article
Serum Nutritional Markers as Prognostic Factors for Hepatic and Extrahepatic Carcinogenesis in Japanese Patients with Nonalcoholic Fatty Liver Disease.
- Published in:
- Nutrition & Cancer, 2020, v. 72, n. 5, p. 884, doi. 10.1080/01635581.2019.1653474
- By:
- Publication type:
- Article
Impact of Branched-Chain Amino Acid Granule Therapy in Patients with Hepatocellular Carcinoma Who Have Normal Albumin Levels and Low Branched-Chain Amino Acid to Tyrosine Ratios.
- Published in:
- Nutrition & Cancer, 2019, v. 71, n. 7, p. 1132, doi. 10.1080/01635581.2019.1597905
- By:
- Publication type:
- Article
Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naive Genotype 1b Chronic Hepatitis C Patients.
- Published in:
- Gastroenterology Research & Practice, 2014, p. 1, doi. 10.1155/2014/549709
- By:
- Publication type:
- Article
Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 11, p. 2415
- By:
- Publication type:
- Article
Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.
- Published in:
- Therapeutic Apheresis & Dialysis, 2017, v. 21, n. 5, p. 465, doi. 10.1111/1744-9987.12563
- By:
- Publication type:
- Article
Eight-week regimen of antiviral combination therapy with peginterferon and ribavirin for patients with chronic hepatitis C with hepatitis C virus genotype 2 and a rapid virological response.
- Published in:
- Liver International, 2009, v. 29, n. 1, p. 120, doi. 10.1111/j.1478-3231.2008.01736.x
- By:
- Publication type:
- Article
Relationship between Lens culinaris agglutinin-reactive α-fetoprotein and pathologic features of hepatocellular carcinoma.
- Published in:
- Liver International, 2005, v. 25, n. 4, p. 848, doi. 10.1111/j.1478-3231.2005.01111.x
- By:
- Publication type:
- Article
Assessment of tumor hemodynamics in small hepatocellular carcinoma: comparison of Doppler ultrasonography, angiography-assisted computed tomography, and pathological findings.
- Published in:
- Liver International, 2004, v. 24, n. 5, p. 425, doi. 10.1111/j.1478-3231.2004.0932.x
- By:
- Publication type:
- Article
Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection.
- Published in:
- European Radiology, 2022, v. 32, n. 7, p. 5016, doi. 10.1007/s00330-022-08570-4
- By:
- Publication type:
- Article
Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.
- Published in:
- European Radiology, 2014, v. 24, n. 9, p. 2157, doi. 10.1007/s00330-014-3254-2
- By:
- Publication type:
- Article
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316
- By:
- Publication type:
- Article
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
- Published in:
- Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676
- By:
- Publication type:
- Article
Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521
- By:
- Publication type:
- Article
Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 65, doi. 10.1159/000520292
- By:
- Publication type:
- Article
Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896
- By:
- Publication type:
- Article
Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293
- By:
- Publication type:
- Article